Diabetes and Alzheimer's Disease: Can Tea Phytochemicals Play a Role in Prevention?

  title={Diabetes and Alzheimer's Disease: Can Tea Phytochemicals Play a Role in Prevention?},
  author={Warnakulasuriya M.A.D.B. Fernando and Geeshani Somaratne and Kathryn Goozee and Shehan S. Williams and Harjinder Singh and Ralph N. Martins},
  journal={Journal of Alzheimer's disease : JAD},
  volume={59 2},
Dementia and diabetes mellitus are prevalent disorders in the elderly population. While recognized as two distinct diseases, diabetes has more recently recognized as a significant contributor to risk for developing dementia, and some studies make reference to type 3 diabetes, a condition resulting from insulin resistance in the brain. Alzheimer's disease, the most common form of dementia, and diabetes, interestingly, share underlying pathological processes, commonality in risk factors, and… 

Figures and Tables from this paper

Role of Tea and Its Components in Treatment of Neurodegenerative Diseases: A Review

The objective of this review is to summarize all the available information on different bioactive components of tea in the treatment of different neurodegenerative diseases.

Polyphenols in Alzheimer’s Disease and in the Gut–Brain Axis

It is hypothesized that gut bacterial metabolism-derived polyphenols, when combined with the nanoparticle-based blood–brain barrier (BBB)-targeted drug delivery, may prove to be effective therapeutics for various neurological disorders, including traumatic brain injury (TBI), AD, and PD.

Role of Natural Compounds and Target Enzymes in the Treatment of Alzheimer’s Disease

The aim of this review was to provide a brief summary of AD and its current therapies, followed by a discussion of the natural compounds examined as therapeutic agents and the processes underlying the positive effects, particularly the management of AD.

The Protective Role of Scoparia Dulcis Linn. in Alzheimer’s Disease

This study suggests that S. dulcis is a potential agent for drug development against AD because of its protein and lipid protection against damage caused by the free radical and anticholinesterase properties, which are relevant to AD therapy.

A Review of the Properties of Anthocyanins and Their Influence on Factors Affecting Cardiometabolic and Cognitive Health

The effects of anthocyanins in in-vitro, animal and human studies are summarized to give an overview of their application in medical prevention or as a dietary supplement.

Anthocyanins Potentially Contribute to Defense against Alzheimer’s Disease

This study presents a literature review of ANTs from different berries and their potential therapeutic value, with particular emphasis on neurodegenerative AD, which owing to oxidative stress is known to cause Alzheimer's disease.

Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies

The journey from the discovery of the Aβ peptide in Alzheimer’s disease (AD) brain to the establishment of pre-clinical AD using PET amyloid tracers, a method now serving as the gold standard for developing peripheral diagnostic approaches in the blood and the eye is discussed.

Association of Tea Consumption with Risk of Alzheimer’s Disease and Anti-Beta-Amyloid Effects of Tea

Empirical studies on the association between tea consumption and the reduced risk of AD are reviewed and the anti-amyloid effects of related bioactivities in tea are summarized.

A Review of the Health Benefits of Tea: Implications of the Biochemical Properties of the Bioactive Constituents

The paper covers the numerous health advantages of tea, focusing on the specific components contributing to such benefits, and stresses the value of diverse brewing processes.

Iron Homeostasis Disorder and Alzheimer’s Disease

The recent progress in the relationship between iron and AD is reviewed from the aspects of iron absorption in intestinal cells, storage and regulation of iron in cells and organs, especially for theregulation of iron homeostasis in the human brain and prospects the future directions for AD treatments.



Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration?

The potential beneficial effects of tea consumption and tea phytochemicals on DM and how their action can counteract the severe brain damage induced by this disease are discussed.

Natural compounds and plant extracts as therapeutics against chronic inflammation in Alzheimer's disease--a translational perspective.

The evidence suggests that increased consumption of these compounds might lead to a safe strategy to delay the onset of AD, and the continuing investigation of the potential of these substances is necessary as they are promising to yield a possible remedy for this pervasive disease.

Neuroprotective potential of phytochemicals

It was observed in the review that a number of herbal medicines used in Ayurvedic practices as well Chinese medicines contain multiple compounds and phytochemicals that may have a neuroprotective effect which may prove beneficial in different neuropsychiatric and neurodegenerative disorders.

Vascular risk factors, cognitve decline, and dementia

Vascular risk factors and their treatments are a promising avenue of research for prevention of dementia, and further long-term, placebo-controlled, randomized studies, need to be performed.

Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults – a review

Although green tea has therapeutic potential in the treatment of obese individuals, the findings of this review demonstrate the need for a greater number of studies to confirm the positive effects of green tea, especially regarding the modulation of obesity.

Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications.

Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease

The contributions of impaired insulin and IGF signaling to AD-associated neuronal loss, synaptic disconnection, tau hyperphosphorylation, amyloid-beta accumulation, and impaired energy metabolism are reviewed and current therapeutic strategies are discussed.

Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome

Understanding the relationship between MetS and AD is vital for the identification of potential therapeutic targets and several diabetes therapies that enhance insulin signaling are being tested for a potential therapeutic benefit in AD and dementia.

Tea, flavonoids, and nitric oxide-mediated vascular reactivity.

Because tea is a popular beverage worldwide, and several studies have shown that it is protective against CVD, further studies are needed to determine the role of tea in primary and secondary cardiovascular prevention.

Neuroprotective molecular mechanisms of (−)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties

Recent literature strengthens the perception that diverse molecular signaling pathways, participating in the neuroprotective activity of the major green tea polyphenol, (−)-epigallocatechin-3-gallate (EGCG), renders this natural compound as potential agent to reduce the risk of various neurodegenerative diseases.